conv.

All stories
HealthActive · 14h

Major review finds no convincing link between Tylenol use in pregnancy and autism

An umbrella review analyzing over 3 million participants shows apparent risk diminishes as study quality improves.

What to know

  • A major umbrella review of over 3 million participants found no convincing link between acetaminophen (Tylenol) use in pregnancy and autism risk.
  • The apparent association between the two weakens substantially as study quality improves, suggesting earlier lower-quality studies may have inflated the risk.
  • The findings provide reassurance about the safety of Tylenol use during pregnancy, a common over-the-counter pain reliever.

“An umbrella review of more than 3 million participants finds the apparent risk shrinks toward zero as study quality rises.”

Forbes · Forbes ↗

Mary Whitfill Roeloffs Forbes Staff reporter

How it unfolded 1 development · click the chart to see its coverage articlesposts

Peak 3 pieces in one half hour at Yesterday, 9 AM; 3 pieces over 15 hours (1 article · 2 posts) Yesterday, 9:58 AM — 3 pieces · 1 article · 2 posts — Bluesky 1, Mastodon 1, Newswires 1Yesterday, 10:28 AM — quietYesterday, 10:58 AM — quietYesterday, 11:28 AM — quietYesterday, 11:58 AM — quietYesterday, 12:28 PM — quietYesterday, 12:58 PM — quietYesterday, 1:28 PM — quietYesterday, 1:58 PM — quietYesterday, 2:28 PM — quietYesterday, 2:58 PM — quietYesterday, 3:28 PM — quietYesterday, 3:58 PM — quietYesterday, 4:28 PM — quietYesterday, 4:58 PM — quietYesterday, 5:28 PM — quietYesterday, 5:58 PM — quietYesterday, 6:28 PM — quietYesterday, 6:58 PM — quietYesterday, 7:28 PM — quietYesterday, 7:58 PM — quietYesterday, 8:28 PM — quietYesterday, 8:58 PM — quietYesterday, 9:28 PM — quietYesterday, 9:58 PM — quietYesterday, 10:28 PM — quietYesterday, 10:58 PM — quietYesterday, 11:28 PM — quietYesterday, 11:58 PM — quietToday, 12:28 AM — quiet 1
12 PM4 PM8 PMnow · 12:58 AM ET
  1. 1
    1. 1 outlet first by Forbes Business, 14h ago · read ↗

    • forbes.com

      An umbrella review of more than 3 million participants finds the apparent risk shrinks toward zero as study quality rises.

      forbes.comBluesky14h ago1.4k▲view on Bluesky ↗